Position in LLY
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$1,703,190
+$377,802 QoQ
Shares Held
1,420
-1.5% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
1.07%
of 13F equity value
Holder Rank
#2,641
of 4,605 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026McLean Asset Management Corp holds $5,605,267 across 9 Drug Manufacturers - General names. LLY ranks #1 (30.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
1,420 | $1,703,190 | |
| 2 | JNJ |
Johnson & Johnson
|
3,218 | $817,275 | |
| 3 | ABBV |
AbbVie Inc.
|
3,136 | $789,143 | |
| 4 | AZN |
Astrazeneca PLC
|
3,240 | $614,368 | |
| 5 | MRK |
Merck & Co., Inc.
|
3,870 | $497,295 | |
| 6 | AMGN |
Amgen Inc
|
1,064 | $385,295 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
6,472 | $372,916 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
1,768 | $223,369 |
All Filings in LLY
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,703,190 | 1,420 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $1,325,388 | 1,441 | Shares | Sole | 2026-04-22 | |
| 2025-12-31 | $1,540,016 | 1,433 | Shares | Sole | 2026-01-16 | |
| 2025-09-30 | $1,117,795 | 1,465 | Shares | Sole | 2025-10-07 | |
| 2025-06-30 | $1,165,397 | 1,495 | Shares | Sole | 2025-07-03 | |
| 2025-03-31 | $1,231,431 | 1,491 | Shares | Sole | 2025-04-09 | |
| 2024-12-31 | $1,128,664 | 1,462 | Shares | Sole | 2025-01-22 | |
| 2024-09-30 | $1,546,851 | 1,746 | Shares | Sole | 2024-10-07 | |
| 2024-06-30 | $1,336,340 | 1,476 | Shares | Sole | 2024-07-12 | |
| 2024-03-31 | $1,117,928 | 1,437 | Shares | Sole | 2024-04-10 | |
| 2023-12-31 | $837,073 | 1,436 | Shares | Sole | 2024-01-08 | |
| 2023-09-30 | $772,930 | 1,439 | Shares | Sole | 2023-10-12 | |
| 2023-06-30 | $674,862 | 1,439 | Shares | Sole | 2023-07-10 | |
| 2023-03-31 | $485,252 | 1,413 | Shares | Sole | 2023-04-11 | |
| 2022-12-31 | $583,880 | 1,596 | Shares | Sole | 2023-01-19 | |
| 2022-09-30 | $485,025 | 1,500 | Shares | Sole | 2022-10-12 | |
| 2022-06-30 | $476,293 | 1,469 | Shares | Sole | 2022-07-07 | |
| 2022-03-31 | $402,349 | 1,405 | Shares | Sole | 2022-04-08 | |
| 2021-12-31 | $378,973 | 1,372 | Shares | Sole | 2022-01-14 | |
| 2021-09-30 | $317,462 | 1,374 | Shares | Sole | 2021-10-27 | |
| 2021-06-30 | $281,162 | 1,225 | Shares | Sole | 2021-07-19 | |
| 2021-03-31 | $211,106 | 1,130 | Shares | Sole | 2021-04-28 | |
| No filing history on record for this holder in this stock. | ||||||